Christina Lockwood, PhD, will serve as president-elect starting in August 2026, followed by a term as president in 2027.


The Association for Diagnostics & Laboratory Medicine (ADLM) has elected Christina Lockwood, PhD, to serve as president-elect of the ADLM board of directors starting in August 2026. Lockwood will subsequently serve as the association’s president from August 2027 to July 2028 and as past president from August 2028 to July 2029.

The membership also elected a new secretary and two new directors to the board. These leaders will take office in August 2026 alongside the incoming president of the ADLM and the incoming chair of the Medical Laboratory Scientists Council.

“Laboratory medicine is evolving rapidly, and the pace of change makes ADLM’s work more important than ever,” says Lockwood, professor of laboratory medicine and pathology at the University of Washington School of Medicine, in a release. “Every day, our field helps translate scientific discoveries and new technologies into better care for patients.”

Lockwood currently serves as division head of laboratory genetics, director of the Genetics and Solid Tumor Diagnostics Laboratory, and clinical director of the Northwest Genomics Center in Seattle. Her work focuses on implementing molecular and bioinformatics approaches in clinical genomic testing. According to the association, Lockwood has contributed to national efforts in laboratory quality, compliance, and regulation through service with the Association for Molecular Pathology, College of American Pathologists, and the National Institutes of Health.

New Board and Council Members

M. Laura Parnas, PhD, will serve as secretary from August 2026 to July 2029. Parnas is senior director of medical affairs at Sysmex America, where she leads clinical initiatives across the company’s diagnostic portfolio. She previously served as director of clinical chemistry at Sutter Health’s Shared Laboratory.

Danyel H Tacker, PhD, and Alison Woodworth, PhD, will join the board as directors for terms ending in 2029. Tacker is a clinical professor of pathology at West Virginia University and serves as medical director of the special chemistry and mass spectrometry sections of the JW Ruby Memorial Hospital Laboratory. Woodworth is clinical director for global laboratory services at CTI Clinical Trials & Consulting and has more than 20 years of experience in clinical laboratory medicine.

Patrick Kyle, PhD, will serve on the board from August 2026 to July 2027 as president of the ADLM. Additionally, Vipul C Shah will serve as chair of the Medical Laboratory Scientists Council during the same period. Shah guides activities to serve the professional needs of the association’s medical laboratory scientist members.

Nominating Committee Elections

The membership also elected Amy Karger, MD, PhD, Joe Wiencek, PhD, and Kalen Nissen, PhD, to the nominating committee. They will serve from August 2026 to July 2029.

Karger is a professor in the department of laboratory medicine and pathology at the University of Minnesota. Wiencek is an associate professor in the department of pathology, microbiology, and immunology at Vanderbilt University School of Medicine. Nissen is senior director and medical officer across the point of care and laboratory solutions businesses at Siemens Healthineers.

The nominating committee is responsible for ensuring the association’s leadership represents the full breadth of the membership, according to a press release from the ADLM.

ID 120432823 © Andrii Yalanskyi | Dreamstime.com